Hyster-Yale (HY) Insider Alison Rankin Buys $766 of Stock
Alison Rankin purchased 20 shares of HY, reflecting ongoing insider activity.
Reviewed by automated data checks against the source filing. How we make and check alerts
Alison Rankin bought 20 shares of Hyster-Yale, Inc. ($HY) at an average price of $38.30, worth about $766, on June 15, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $HY is up 2.4% after 1 week, down 11.6% after 1 month and down 21.5% to date (from the $37.23 close on Jun 15, 2026).
HY
Hyster-Yale, Inc.
Key Points
- Alison Rankin purchased 20 shares of HY at $38.3 each on June 15, 2026, for a total value of $766.
- Shares of HY traded near $37.55, with significant institutional activity from BlackRock and Vanguard.
- Analysts from Roth MKM and Northland reiterated buy ratings with price targets of up to $90.
Get $HY trade alerts by text
We text you when insiders, Congress or big funds trade $HY. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Hyster-Yale, Inc. alert may contain errors. Disclosures
On June 15, 2026, Alison Rankin purchased 20 shares of HY at an average price of $38.3 per share, totaling $766. This transaction adds to the ongoing insider activity at the company.
Insider Buying and Selling at Hyster-Yale, Inc.
Alison Rankin's recent purchase of 20 shares at $38.3 each wasn't part of a pre-arranged trading plan. The same day saw other insiders, including Elisabeth Rankin and Alfred Rankin, each involved in similar transactions, but they were sellers. This activity highlights a range of insider trading actions within HY.
Other Institutional Activity in HY
Several institutional investors have made moves in HY recently. BlackRock, Inc. increased its holdings by 17,635 shares, bringing its total to 908,512 shares valued at approximately $29.5 million. Dimensional Fund Advisors LP also added 28,642 shares, ending with 587,683 shares worth about $19.1 million. Meanwhile, Vanguard Capital Management LLC initiated a new position with 475,791 shares, valued at around $15.5 million. Conversely, Gamco Investors, Inc. reduced its stake by 23,309 shares, leaving it with 811,057 shares valued at $26.4 million.
Hyster-Yale, Inc. Stock Up 12.0%
Shares of HY are trading around $37.55. The company has seen significant interest from both insiders and institutions, which could impact its market dynamics. With ongoing analyst support and substantial institutional investments, HY remains a stock to watch.
Analysts Set New Price Targets
Analysts remain optimistic about HY's prospects. On June 7, 2024, Roth MKM reiterated its buy rating with a price target of $87. Earlier, on June 5, 2024, Northland maintained its buy rating with a $90 target. These targets reflect confidence in HY’s potential, supported by a consensus recommendation leaning towards a buy.
Bottom Line
Alison Rankin's recent purchase of HY shares is part of a broader pattern of insider and institutional activity. While insider actions can provide insights into management's outlook, it's important to consider them alongside analyst ratings and institutional moves. Investors should note that these transactions are historical and may not reflect current positions.
Related Filing Alerts
Source: Alison Rankin's Form 4 filing on $HY (Jun 15, 2026). Find the original filing: HY Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts